News Articles Tagged: Darunavir Analogs

From Computation to Clinic: Developing Advanced HIV-1 Protease Inhibitors

Trace the journey from computational modeling to potential clinical application for novel HIV-1 protease inhibitors, exemplified by the development of improved Darunavir analogs.

Innovating HIV Treatment: Computational Screening of Darunavir Analogs for Potency and Resistance

Learn how computational screening methods are identifying new Darunavir analogs with enhanced potency and improved resistance profiles for better HIV treatment outcomes.

Combating HIV-1 Resistance: The Power of Structure-Based Drug Design with Darunavir Analogs

Learn how structure-based drug design (SBDD) is being used with Darunavir analogs to create new HIV-1 treatments that overcome drug resistance.

Understanding HIV-1 Resistance: A Computational Deep Dive into Darunavir Analogs

Explore how computational chemistry, including FMO methods, is used to design new Darunavir analogs to combat HIV-1 drug resistance, leading to more effective treatments.